Faeth Therapeutics, Inc. (FTH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$20.34

From 52W high−50.09%

Volume235960.00

Market cap$516.62M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$20.34

From 52W high

−50.09%

Volume

235960.00

Market cap

$516.62M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.6x

P/E (TTM)

—

RSI (14)

38.2

MomentumView details →

1D Return

+1.73%

YTD Return

+80.92%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.6x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

3.2x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−131.20%

ROA (TTM)

−118.11%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+30.36%

EBITDA YoY

—

MomentumView details →

1D Return

+1.73%

YTD Return

+80.92%

1Y Return

+117.64%

RSI (14)

38.2

vs 50D SMA

−30.91%

vs 200D SMA

−23.62%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

16.12x

Quick Ratio

16.12x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.79

EPS Surprise

−1.07%

Beats (12Q)

0/12

Next Q EPS Est

−$0.77

Avg Surprise (4Q)

−4.32%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−211.36M

Op. CF (TTM)

−43.27M

Next earningsMar 29, 2027 →

Latest newsMore news →

No recent news for FTH.

Similar companies

Shattuck Labs, Inc.STTK Capricor Therapeutics, Inc.CAPR Crescent Biopharma, Inc.CBIO CytomX Therapeutics, Inc.CTMX REGENXBIO Inc.RGNX XOMA Royalty Corp.XOMA Find similar companies →

Latest newsMore news →

No recent news for FTH.